Ishikawa Hitoshi, Ishikawa Takashi, Yamamoto Hidetaka, Fukao Akira, Yokoyama Kazuhito
Department of Public Health and Occupational Medicine, Mie University Graduate School of Medicine, Edobashi 2-174, Tsu 514-8507, Japan.
Mutat Res. 2007 Feb 3;615(1-2):134-42. doi: 10.1016/j.mrfmmm.2006.11.026.
Ethanol is almost totally broken down by oxidative metabolism in vivo. Ethanol per se is considered to be neither carcinogenic, mutagenic nor genotoxic. However, during the metabolic conversion of ethanol to acetaldehyde and acetate, the organism is exposed to both ethanol and acetaldehyde and therefore ethanol is suspected to be co-carcinogenic. The genetic polymorphisms of alcohol dehydrogenase-2 (ADH1B) and acetaldehyde dehydrogenase-2 (ALDH2) influence the metabolism of alcohol. The ADH1B*1/1 genotype encodes the low-activity form of ADH1B, and ALDH21/2 and ALDH22/2 genotype encode inactive ALDH2. The aim of this study was to test the hypothesis that polymorphisms of the ADH1B and ALDH2 genes are significantly associated with genotoxicity induced by alcohol drinking, measured using the cytokinesis-block micronucleus (CBMN) assay, an established biomarker of genome instability, in peripheral blood lymphocytes of 286 healthy Japanese men. There was a significant trend for the mean micronuclei (MN) frequency in habitual or moderate drinkers without a smoking habit to increase as the numbers of the 1 allele in ADH1B increased (P=0.039 or P=0.029) and the 2 allele in ALDH2 increased (P=0.019 or P=0.037). A logistic regression analysis showed that the number of subjects with MN frequency levels more than median value of MN (3.0) was significantly higher in the subjects with the ADH1B1 allele as adjusted estimates (OR 2.08, 95% C.I. 1.24-3.48), when the OR for the subjects with the ADH1B2/2 genotype was defined as 1.00. The number of subjects with MN frequency levels more than median value of MN was also significantly higher in the subjects with the ALDH22 allele as adjusted estimates (OR 1.79, 95% C.I. 1.04-3.11), when the OR for the subjects with the ALDH21/*1 genotype was defined as 1.00. The results of this study have identified important novel associations between ADH1B/ALDH2 polymorphisms and genotoxicity in alcohol drinkers.
乙醇在体内几乎完全通过氧化代谢分解。乙醇本身被认为既无致癌性、致突变性也无基因毒性。然而,在乙醇代谢转化为乙醛和乙酸的过程中,机体暴露于乙醇和乙醛两者,因此乙醇被怀疑具有协同致癌性。酒精脱氢酶-2(ADH1B)和乙醛脱氢酶-2(ALDH2)的基因多态性会影响酒精的代谢。ADH1B1/1基因型编码低活性形式的ADH1B,而ALDH21/2和ALDH22/2基因型编码无活性的ALDH2。本研究的目的是检验以下假设:ADH1B和ALDH2基因的多态性与饮酒诱导的基因毒性显著相关,通过胞质分裂阻滞微核(CBMN)试验来测量,该试验是一种已确立的基因组不稳定性生物标志物,用于检测286名健康日本男性外周血淋巴细胞中的基因毒性。对于无吸烟习惯的习惯性或适度饮酒者,随着ADH1B中1等位基因数量的增加(P=0.039或P=0.029)以及ALDH2中2等位基因数量的增加(P=0.019或P=0.037),平均微核(MN)频率存在显著上升趋势。逻辑回归分析表明,当将ADH1B2/2基因型受试者的比值比定义为1.00时,经调整估计,ADH1B1等位基因受试者中微核频率水平超过微核中位数(3.0)的受试者数量显著更高(比值比2.08,95%置信区间1.24 - 3.48)。当将ALDH21/1基因型受试者的比值比定义为1.00时,经调整估计,ALDH22等位基因受试者中微核频率水平超过微核中位数的受试者数量也显著更高(比值比1.79,95%置信区间1.04 - 3.十一)。本研究结果确定了ADH1B/ALDH2多态性与饮酒者基因毒性之间重要的新关联。